BioNTech eyes vaccine for 12-15-year-olds from June

BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June. The German firm’s CEO Ugur Sahin told Der Spiegel weekly that it was “in the final stretches” of preparing its submission for European regulatory approval.  The evaluation of the trial data
The post BioNTech eyes vaccine for 12-15-year-olds from June appeared first on Asia Times.Asia TimesRead More